Literature DB >> 9752638

A time-limited behavioral group for treatment of obsessive-compulsive disorder.

B L Van Noppen1, M T Pato, R Marsland, S A Rasmussen.   

Abstract

In vivo exposure with response prevention is an effective treatment for obsessive-compulsive disorder (OCD) either alone or combined with pharmacotherapy. Widespread application of this technique has been limited by lack of trained therapists and the expense of intensive individual behavioral therapy. This report describes a time-limited 10-session behavioral therapy group for OCD whose key elements are exposure, response prevention, therapist and participant modeling, and cognitive restructuring. In a naturalistic open trial of 90 patients meeting DSM-III-R criteria for OCD who completed the 10-session group, self-administered Yale-Brown Obsessive-Compulsive Scale scores (mean +/- SD) were 21.8 +/- 5.6 at baseline and 16.6 +/- 6.4 after the 10-week treatment, a significant decrease. A descriptive analysis of the therapeutic elements of the group and its advantages over individual behavioral treatment are presented.

Entities:  

Mesh:

Year:  1998        PMID: 9752638      PMCID: PMC3330509     

Source DB:  PubMed          Journal:  J Psychother Pract Res        ISSN: 1055-050X


  13 in total

1.  Treatment of chronic obsessive-compulsive neurosis by in-vivo exposure. A two-year follow-up and issues in treatment.

Authors:  I M Marks; R Hodgson; S Rachman
Journal:  Br J Psychiatry       Date:  1975-10       Impact factor: 9.319

2.  Exposure in vivo of agoraphobics: contributions of diazepam, group exposure, and anxiety evocation.

Authors:  J Hafner; I Marks
Journal:  Psychol Med       Date:  1976-02       Impact factor: 7.723

3.  Group exposure (flooding) in vivo for agoraphobics.

Authors:  I Hand; Y Lamontagne; I M Marks
Journal:  Br J Psychiatry       Date:  1974-06       Impact factor: 9.319

4.  Group exposure for agoraphobics: a replication study.

Authors:  J D Teasdale; P A Walsh; M Lancashire; A M Mathews
Journal:  Br J Psychiatry       Date:  1977-02       Impact factor: 9.319

5.  Six-year follow-up after exposure and clomipramine therapy for obsessive compulsive disorder.

Authors:  G O'Sullivan; H Noshirvani; I Marks; W Monteiro; P Lelliott
Journal:  J Clin Psychiatry       Date:  1991-04       Impact factor: 4.384

6.  A controlled trial of fluvoxamine in obsessive-compulsive disorder: implications for a serotonergic theory.

Authors:  M A Jenike; S Hyman; L Baer; A Holland; W E Minichiello; L Buttolph; P Summergrad; R Seymour; J Ricciardi
Journal:  Am J Psychiatry       Date:  1990-09       Impact factor: 18.112

7.  A standardized behavioral group treatment program for obsessive-compulsive disorder: preliminary outcomes.

Authors:  K P Krone; J A Himle; R M Nesse
Journal:  Behav Res Ther       Date:  1991

8.  Efficacy and tolerability of serotonin transport inhibitors in obsessive-compulsive disorder. A meta-analysis.

Authors:  J H Greist; J W Jefferson; K A Kobak; D J Katzelnick; R C Serlin
Journal:  Arch Gen Psychiatry       Date:  1995-01

9.  The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability.

Authors:  W K Goodman; L H Price; S A Rasmussen; C Mazure; R L Fleischmann; C L Hill; G R Heninger; D S Charney
Journal:  Arch Gen Psychiatry       Date:  1989-11

10.  Clomipramine and exposure for chronic obsessive-compulsive rituals: III. Two year follow-up and further findings.

Authors:  D Mawson; I M Marks; L Ramm
Journal:  Br J Psychiatry       Date:  1982-01       Impact factor: 9.319

View more
  3 in total

1.  Behavioral Therapy Teams for Obsessive-Compulsive Disorder: Lessons Learned From a Pilot Randomized Trial in a Community Mental Health Center.

Authors:  Maria C Mancebo; Agustin G Yip; Christina L Boisseau; Steven A Rasmussen; Caron Zlotnick
Journal:  Behav Ther       Date:  2021-03-02

2.  Latinos with obsessive-compulsive disorder: Mental healthcare utilization and inclusion in clinical trials.

Authors:  Chad T Wetterneck; Tannah E Little; Kimberly L Rinehart; Maritza E Cervantes; Emma Hyde; Monnica Williams
Journal:  J Obsessive Compuls Relat Disord       Date:  2012-01-08       Impact factor: 1.677

Review 3.  Patient-reported outcomes in obsessive-compulsive disorder.

Authors:  Mythily Subramaniam; Pauline Soh; Clarissa Ong; Lee Seng Esmond Seow; Louisa Picco; Janhavi Ajit Vaingankar; Siow Ann Chong
Journal:  Dialogues Clin Neurosci       Date:  2014-06       Impact factor: 5.986

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.